ContraVir Pharmaceuticals Inc. (CTRV)

3.25
0.33 9.09
NASDAQ : Health Technology
Prev Close 3.58
Open 3.47
Day Low/High 3.12 / 3.56
52 Wk Low/High 3.52 / 91.00
Volume 131.92K
Avg Volume 3.89M
Exchange NASDAQ
Shares Outstanding 803.00K
Market Cap 2.87M
EPS -97.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ContraVir Pharmaceuticals Announces Research Collaboration Agreement With Li Ka Shing Institute Of Virology

ContraVir Pharmaceuticals Announces Research Collaboration Agreement With Li Ka Shing Institute Of Virology

Collaboration Aimed Towards Reaching a Cure for Hepatitis B Virus (HBV) Infection

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

Achillion Shares Are Plunging on Termination of Hepatitis C Pact

The New Haven, Conn.-based firm on Sept. 9 received a termination notice regarding its license and collaboration pact with Johnson & Johnson's Janssen Pharmaceuticals Inc. on hepatitis C.

ContraVir To Advance Second-Generation Formulation Of Tenofovir Exalidex (TXL™) For Treatment Of Hepatitis B Virus (HBV)

Dose Escalation Not Required For First Generation Formulation of TXL™